Sonoma Pharmaceuticals, Inc.

( )
SNOA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -0.14%70.055.6%$171.10m
VRXValeant Pharmaceuticals International, Inc. -1.93%19.3014.1%$113.56m
CTLTCatalent, Inc. -3.29%99.932.1%$112.88m
BHCBausch Health Cos., Inc. -1.93%19.300.0%$83.28m
JAZZJazz Pharmaceuticals Plc 0.85%144.312.4%$80.07m
UTHRUnited Therapeutics Corp. 1.29%137.7714.1%$66.02m
GWPHGW Pharmaceuticals Plc 0.50%125.446.1%$65.83m
PRGOPerrigo Co. Plc -0.77%47.746.8%$55.27m
SAGESAGE Therapeutics, Inc. 2.35%77.978.6%$41.13m
ICLRICON plc -0.98%187.824.2%$37.24m
ARGXargenx SE -0.12%269.000.0%$36.20m
SAVACassava Sciences, Inc. -3.14%7.100.0%$34.17m
BLRXBioLineRx Ltd. -13.64%2.281.8%$33.30m
AMRNAmarin Corp. Plc -3.46%4.461.5%$33.20m
CORTCorcept Therapeutics, Inc. -3.89%23.005.4%$32.29m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.